Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Monday, March 3, 2008

Palomar cuts a new hair-removal tech deal with P&G

Palomar Medical Technologies Inc., a maker of light-based systems for cosmetic treatments, has amended a licensing deal for a hair-removal product it has with the Procter & Gamble Co.

P&G has agreed to pay Palomar $1.25 million per quarter until the product is launched, followed by a deal based on the product's sales.

Burlington-based Palomar (Nasdaq: PMTI) said it reached the initial agreement in February 2003 with the Gillette Co., which was then acquired for $55 billion in 2005 by consumer products giant P&G, based in Cincinatti.

The deal was for Palomar to develop a home hair-removal product for women and license it to Gillette. Under the new agreement, Palomar has granted P&G nonexclusive licences to its patent portfolio and its technology for home hair removal.

After the product launch, P&G will pay Palomar an undisclosed amount based on sales. The U.S. Food and Drug Administration has cleared the product for the home market, according to Palomar.

Palomar reported a 2007 profit of $20.5 million, with revenue of $123.8 million. The firm employs 225 workers.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.